Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Abdelmalik Slassi

Abdelmalik Slassi, Ontario CA

Patent application numberDescriptionPublished
200901118111,2,4-TRIAZOLE CARBOXYLIC ACID DERIVATIVES AS MODULATORS OF MGLUR5 - The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.04-30-2009
20090111824AMIDE LINKED HETEROAROMATIC DERIVATIVES AS MODULATORS OF MGLUR5 - The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.04-30-2009
200901118571,2,4-TRIAZOLE ETHER DERIVATIVES AS MODULATORS OF MGLUR5 - The present invention is directed to novel compounds, to a process for their preparation, their use in therapy and pharmaceutical compositions comprising the novel compounds.04-30-2009
20090131454New compounds 067 - The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.05-21-2009
20100144710Piperazine and Piperidine MGLUR5 Potentiators - Compounds of Formula I or pharmaceutically acceptable salts or solvates thereof, wherein A, B, D, Ar1, Ar2, R2, R3, R4, a, m and n are defined in the specification, methods for the use thereof, processes for making and pharmaceutical compositions containing the same.06-10-2010
20100267740Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842 - Compounds of Formula (I) wherein R10-21-2010

Patent applications by Abdelmalik Slassi, Ontario CA

Abdelmalik Slassi, Toronto CA

Patent application numberDescriptionPublished
20090005433Fluorinated Compounds - Compounds of Formula I are useful in the treatment of epilepsy, neuropathic pain, acute and chronic inflammatory pain, migraine, tardive dyskinesia and other related CNS disorders.01-01-2009
20090275578Isoindolone compounds and their use as metabotropic glutamate receptor potentiators - The present invention is directed to compounds of formula I:11-05-2009

Patent applications by Abdelmalik Slassi, Toronto CA